AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24482383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued ≥5 days before surgery)
Number of subjects: 405
Study 24482383 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (discontinued ≥5 days before surgery)
Number of subjects: 405
Study 24482383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued 2-4 days before surgery)
Number of subjects: 405
Study 24482383 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (discontinued 2-4 days before surgery)
Number of subjects: 405
Study 24482383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (discontinued 0-1 day before surgery)
Number of subjects: 405
Study 24482383 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (discontinued 0-1 day before surgery)
Number of subjects: 405
Study 22362058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial health warnings with graphic depictions of disease
Number of subjects: 1072
Study 22362058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial health warnings with symbolic images or experiences of human suffering
Number of subjects: 1072
Study 22362058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings with testimonial information
Number of subjects: 1072
Study 22362058 — intervention group
Group type: COMPARATOR
Intervention: Text-only warnings
Number of subjects: 1072
Study 20811658 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 mg NRT
Number of subjects: 369
Study 20811658 — intervention group
Group type: EXPERIMENTAL
Intervention: 42 mg NRT
Number of subjects: 369
Study 17245057 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeeter drill technique
Number of subjects: 336
Study 17245057 — intervention group
Group type: EXPERIMENTAL
Intervention: CO(2) laser technique
Number of subjects: 336
Study 15588744 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimization allocation method
Number of subjects: 2158
Study 15588744 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic allocation (minimization)
Number of subjects: 2158
Study 15588744 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted tests for allocation factors as covariates
Number of subjects: 2158
Study 12040250 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonist (Ca‐A)
Number of subjects: 9000
Study 12040250 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin‐converting enzyme inhibitor (ACE‐I)
Number of subjects: 9000
Study 12040250 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor antagonist (ARB)
Number of subjects: 9000
Study 9803001 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal approach (group A)
Number of subjects: 88
Study 9803001 — intervention group
Group type: EXPERIMENTAL
Intervention: Inguinal approach (group B)
Number of subjects: 88
Study 9803001 — intervention group
Group type: EXPERIMENTAL
Intervention: Subinguinal approach (group C)
Number of subjects: 88
Study 9803001 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous venous embolization (group D)
Number of subjects: 88
Study 7662980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermetaphase fluorescence in situ hybridization (HMF)
Number of subjects: 70
Study 2183485 — intervention group
Group type: EXPERIMENTAL
Intervention: Etappenlavage with Velcro analogue for temporary abdominal closure
Number of subjects: 117
Study 2183485 — intervention group
Group type: EXPERIMENTAL
Intervention: Etappenlavage with various closure methods (retention sutures, zipper, slide fastener, Velcro analogue)
Number of subjects: 117
Study 2183485 — intervention group
Group type: EXPERIMENTAL
Intervention: Etappenlavage
Number of subjects: 117
Study 2183485 — intervention group
Group type: EXPERIMENTAL
Intervention: Velcro analogue
Number of subjects: 117
Study 7398184 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg
Number of subjects: 5
Study 31164368 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month hybrid closed-loop insulin delivery
Number of subjects: 130
Study 31164368 — intervention group
Group type: COMPARATOR
Intervention: Usual care (conventional or sensor-augmented pump therapy)
Number of subjects: 130
Study 28231777 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication training for personnel and group intervention for patients addressing patient skills for shared decision making (SDM).
Number of subjects: 276
Study 28231777 — intervention group
Group type: COMPARATOR
Intervention: Control condition with treatment as usual.
Number of subjects: 276
Study 25872651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (told they were in an intervention trial)
Number of subjects: 6788
Study 25872651 — intervention group
Group type: COMPARATOR
Intervention: Control group (told they were in an intervention trial and were in the control group)
Number of subjects: 6788
Study 25872651 — intervention group
Group type: COMPARATOR
Intervention: Cohort group (told their drinking would be assessed at baseline and again in one month)
Number of subjects: 6788
Study 25872651 — intervention group
Group type: COMPARATOR
Intervention: Cohort group
Number of subjects: 6788
Study 25872651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6788
Study 25872651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 6788
Study 24064125 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat Whole Lung Lavage (RWLL)
Number of subjects: 60
Study 24064125 — intervention group
Group type: COMPARATOR
Intervention: Whole Lung Lavage (WLL)
Number of subjects: 60
Study 21861771 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day)
Number of subjects: 44
Study 21861771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 19651542 — intervention group
Group type: EXPERIMENTAL
Intervention: eFlow rapid nebulizer
Number of subjects: 25
Study 19651542 — intervention group
Group type: COMPARATOR
Intervention: LC PLUS nebulizer
Number of subjects: 25
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in clinical RCT (group 1a)
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomisation acceptance (group 1a)
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in hypothetical RCT
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient group allocation
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical decision-making preferences
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling of being unable to refuse a doctor's proposal
Number of subjects: 455
Study 17434812 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with doctors' communication
Number of subjects: 455
Study 15067257 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment need assessed by the aesthetic component (AC) of the index of orthodontic treatment need (IOTN)
Number of subjects: 386
Study 15067257 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic treatment need assessed by the dental health component (DHC) of the index of orthodontic treatment need (IOTN)
Number of subjects: 386
Study 15067257 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective need for orthodontic treatment as assessed by a prestructured questionnaire
Number of subjects: 386
Study 15067257 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's perceptions of dental attractiveness based on intraoral photographs
Number of subjects: 386
Study 15067257 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's perceptions of unattractiveness based on photographs showing severe deviations including crowding
Number of subjects: 386
Study 11448721 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0
Study 11448721 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 11448721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9713781 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.4 mg/mL for 2 minutes
Number of subjects: 25
Study 9713781 — intervention group
Group type: COMPARATOR
Intervention: Control balanced salt solution
Number of subjects: 25
Study 7993985 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 750 mg oral dose of Vigabatrin (VGB)
Number of subjects: 0
Study 7993985 — intervention group
Group type: COMPARATOR
Intervention: Standard two-stage techniques
Number of subjects: 0
Study 2678255 — intervention group
Group type: EXPERIMENTAL
Intervention: Endosonography (ES)
Number of subjects: 171
Study 1069012 — intervention group
Group type: EXPERIMENTAL
Intervention: Apically repositioned flap operation including elimination of bony defects
Number of subjects: 50
Study 1069012 — intervention group
Group type: EXPERIMENTAL
Intervention: Apically repositioned flap operation including curettage of the bony defects but without removal of bone
Number of subjects: 50
Study 1069012 — intervention group
Group type: EXPERIMENTAL
Intervention: Widman flap technique including elimination of bony defects
Number of subjects: 50
Study 1069012 — intervention group
Group type: EXPERIMENTAL
Intervention: Widman flap technique including curettage of the bony defects but without removal of bone
Number of subjects: 50
Study 1069012 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingivectomy including curettage of the bony defects but without removal of bone
Number of subjects: 50
Study 31063868 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive goal-setting and incentive interventions for MVPA
Number of subjects: 512
Study 31063868 — intervention group
Group type: COMPARATOR
Intervention: Static-goal-setting and delayed-incentive comparisons
Number of subjects: 512
Study 28599636 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention over 9 months focusing on disease understanding, symptom awareness, inhaler use, personalized plans for physical activity, smoking cessation, and care coordination.
Number of subjects: 0
Study 28599636 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching intervention
Number of subjects: 0
Study 25313850 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position for 6 hours followed by right lateral position for 6 hours
Number of subjects: 34
Study 25313850 — intervention group
Group type: COMPARATOR
Intervention: Supine position throughout the study
Number of subjects: 34
Study 23878838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (various durations and frequencies)
Number of subjects: 100
Study 23878838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking for 4-7 years
Number of subjects: 100
Study 23878838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking for 7-11 cigarettes/day
Number of subjects: 100
Study 23878838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (increased duration and frequency)
Number of subjects: 100
Study 23878838 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoking (control group)
Number of subjects: 100
Study 21864846 — intervention group
Group type: EXPERIMENTAL
Intervention: HRC monitoring displayed
Number of subjects: 3003
Study 21864846 — intervention group
Group type: COMPARATOR
Intervention: Control group (HRC monitoring masked)
Number of subjects: 3003
Study 19186716 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with moxibustion on temperature-sensitive points
Number of subjects: 60
Study 19186716 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study 17367318 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal primary surgery
Number of subjects: 109
Study 17367318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoptimal primary surgery
Number of subjects: 109
Study 17367318 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by surgery
Number of subjects: 109
Study 17367318 — intervention group
Group type: COMPARATOR
Intervention: No cytoreductive surgical procedure
Number of subjects: 109
Study 14736303 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial updating with imagined heading parallel to learning view
Number of subjects: 0
Study 14736303 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial updating with actual and imagined headings the same
Number of subjects: 0
Study 14736303 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of angular difference between learning heading and imagined heading
Number of subjects: 0
Study 14736303 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of angular difference between actual heading and imagined heading
Number of subjects: 0
Study 11286526 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal exercise cycle test
Number of subjects: 30
Study 11286526 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal 6 min walk test
Number of subjects: 30
Study 11286526 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance treadmill test
Number of subjects: 30
Study 9441288 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-lithium cotransport (SLC) activity in patients with IDDM complicated with diabetic nephropathy (group II)
Number of subjects: 51
Study 9441288 — intervention group
Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in patients with IDDM without nephropathy (group I)
Number of subjects: 51
Study 9441288 — intervention group
Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in patients treated with hemodialysis due to non-diabetic nephropathy (group III)
Number of subjects: 51
Study 9441288 — intervention group
Group type: COMPARATOR
Intervention: Sodium-lithium cotransport (SLC) activity in healthy subjects (group IV)
Number of subjects: 51
Study 8201477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (containing PT‐9K/129G, filamentous hemagglutinin, and pertactin)
Number of subjects: 480
Study 8201477 — intervention group
Group type: COMPARATOR
Intervention: Whole-cell pertussis vaccine
Number of subjects: 480
Study 8201477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 480
Study 3318196 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil‐HCl as Isoptin RR 240 mg
Number of subjects: 14
Study 3318196 — intervention group
Group type: EXPERIMENTAL
Intervention: Veramex SR 240
Number of subjects: 14
Study 3318196 — intervention group
Group type: EXPERIMENTAL
Intervention: durasoptin SR 240
Number of subjects: 14
Study 3318196 — intervention group
Group type: COMPARATOR
Intervention: Comparison of the three formulations
Number of subjects: 14
Study 29358543 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders about oral hygiene
Number of subjects: 60
Study 29358543 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text message reminders)
Number of subjects: 60
Study 27699563 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular sutures
Number of subjects: 401
Study 27699563 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 401
Study 25595921 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient care programme (4 weeks duration)
Number of subjects: 514
Study 25595921 — intervention group
Group type: COMPARATOR
Intervention: Usual care (conventional care)
Number of subjects: 514
Study 23742961 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Breast Irradiation (PBI)
Number of subjects: 258
Study 23742961 — intervention group
Group type: COMPARATOR
Intervention: Whole Breast Irradiation (WBI)
Number of subjects: 258
Study 20528820 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge drinking (defined as > or =5 drinks on 1 occasion for men or > or =4 drinks on 1 occasion for women)
Number of subjects: 200587
Study 20528820 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinking (defined as an average of >14 drinks per week for men or >7 drinks per week for women)
Number of subjects: 200587
Study 20528820 — intervention group
Group type: COMPARATOR
Intervention: Nonbinge drinkers
Number of subjects: 200587
Study 18458186 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational young child-oriented media
Number of subjects: 154
Study 18458186 — intervention group
Group type: COMPARATOR
Intervention: Noneducational young child-oriented programs
Number of subjects: 154
Study 18458186 — intervention group
Group type: COMPARATOR
Intervention: School-age/teenage/adult-oriented programs
Number of subjects: 154
Study 18458186 — intervention group
Group type: EXPERIMENTAL
Intervention: Coviewed educational content
Number of subjects: 154
Study 17148703 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins (e.g., Dalteparin, Enoxaparin)
Number of subjects: 0
Study 17148703 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboprophylaxis as recommended by American College of Chest Physicians
Number of subjects: 0
Study 14671179 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone
Number of subjects: 100
Study 11967820 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 6 mg
Number of subjects: 48
Study 11967820 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 123 mg
Number of subjects: 48
Study 11967820 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan 93.5 mg
Number of subjects: 48
Study 11967820 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 54 mg
Number of subjects: 48
Study 11967820 — intervention group
Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 48
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility impairment (balance, leg-extension strength, gait)
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Dizziness upon standing
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor mental state
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural hypotension
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk profile including all five risk factors
Number of subjects: 354
Study 8633602 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of falls in the previous year
Number of subjects: 354
Study 1280715 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 20
Study 1280715 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20
Study 3904315 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 0
Study 3904315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 0
Study 29793876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Group (IG) - Vocal Therapy, 4 times a week for 16 sessions
Number of subjects: 27
Study 29793876 — intervention group
Group type: COMPARATOR
Intervention: Conventional Group - Vocal Therapy, 2 times a week for 16 sessions
Number of subjects: 27
Study 30404619 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced implementation strategy
Number of subjects: 12
Study 30404619 — intervention group
Group type: COMPARATOR
Intervention: Core implementation strategy
Number of subjects: 12
Study 27938918 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg/day)
Number of subjects: 50
Study 27938918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 24585423 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative patching
Number of subjects: 61
Study 24585423 — intervention group
Group type: COMPARATOR
Intervention: No patching (Control)
Number of subjects: 61
Study 22103958 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination pharmacotherapy (nicotine patch + nicotine lozenge, bupropion + nicotine lozenge)
Number of subjects: 1504
Study 22103958 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy (nicotine patch, nicotine lozenge, bupropion)
Number of subjects: 1504
Study 22103958 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatments
Number of subjects: 1504
Study 22103958 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression of craving on the quit day
Number of subjects: 1504
Study 19856202 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat (20% of energy), average protein (15% of energy)
Number of subjects: 811
Study 19856202 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat (40%), average protein (15%)
Number of subjects: 811
Study 19856202 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat (20%), high protein (25%)
Number of subjects: 811
Study 19856202 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat (40%), high protein (25%)
Number of subjects: 811
Study 18019397 — intervention group
Group type: EXPERIMENTAL
Intervention: Pycnogenol (Pyc)
Number of subjects: 0
Study 18019397 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0
Study 16361855 — intervention group
Group type: EXPERIMENTAL
Intervention: AST-120 (charcoal compound), dosage and duration not specified
Number of subjects: 0
Study 16361855 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum (enteric capsules), dosage and duration not specified
Number of subjects: 0
Study 12967792 — intervention group
Group type: EXPERIMENTAL
Intervention: Verteporfin therapy (Visudyne, Novartis AG)
Number of subjects: 0
Study 12967792 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 10948819 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg lactoferrin
Number of subjects: 37
Study 10948819 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg lactoferrin
Number of subjects: 37
Study 10948819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 8773736 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrates (CH; 200 g)
Number of subjects: 8
Study 8773736 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated fatty acids (SAFA; 72%)
Number of subjects: 8
Study 8773736 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acids (PUFA; 60%)
Number of subjects: 8
Study 8773736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-monounsaturated fatty acids (MUFA; 40%)
Number of subjects: 8
Study 1734249 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic nonabsorbable antibiotics (tobramycin, colistin sulfate, and amphotericin B) administered through a nasogastric tube
Number of subjects: 445